Trial Profile
Effect of ferric carboxymaltose on phosphate homeostasis: a prospective cohort study in patients with iron deficiency following bariatric surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2022
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Adverse reactions
- 11 May 2018 New trial record
- 09 May 2018 Status changed from active, no longer recruiting to completed.